If persistent, contact your prescriber about dose adjustment
Mechanism of Action Retatrutides multi-receptor activation leads to: Strong suppression of appetite and food intake (GLP-1 & GIP pathways) Enhanced insulin secretion and glucose control Potential increases in energy expenditure and fat oxidation (glucagon agonism, which may uniquely drive liver fat reduction) Early studies suggest additive benefits beyond tirzepatide or semaglutide, but full long-term data are pending
Less commonly reported side effects have included fatigue, headaches, and mild increases to heart rate
Four 20mg vials for weeks 5-16 (uses 96mg)
QMP engineering improves the PK properties of the GLP-1 albumin fusion following subcutaneous administration Subcutaneous (SC) injection is the most common route of administration for GLP-1 RAs, including Tanzeum 24,25
These medications work by reducing appetite, increasing feelings of fullness, and slowing digestion, which helps decrease calorie intake and promotes sustainable weight loss